Analytical Data
-
Gene name
S100A14
- Application
-
Alternative Names
S100 calcium-binding protein A14 Short name: S114 S100A15
-
Species
Human
-
Source
Yeast
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9HCY8
-
Expression Region
1-104aa
-
Molecular Weight
13.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
S100A14 is a member of the S100 protein family, characterized by its capacity to bind calcium and other metal ions, which induces conformational changes allowing interaction with a variety of target proteins. Research into S100A14 has gained momentum due to its involvement in various cellular processes, such as cell proliferation, differentiation, and apoptosis, as well as its implications in several pathological conditions, including cancer and inflammatory diseases. Increased expression levels of S100A14 have been associated with tumor progression and poor prognosis in various malignancies, indicating its potential role as a biomarker for cancer diagnosis and therapy. Moreover, S100A14's diverse functions and regulatory mechanisms underscore its significance in cell signaling pathways. The study of recombinant S100A14 protein provides valuable insight into its structure-function relationships, enabling a better understanding of its biological activities and interactions at the molecular level. This research is crucial for identifying therapeutic targets and developing novel treatment strategies, particularly in oncology, where S100A14 may serve as a potential therapeutic agent or target for drug development. Through advanced techniques in protein expression and purification, scientists aim to elucidate the precise roles of S100A14 in health and disease, paving the way for its application in clinical settings.
